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Abstract
Background:  Glutathione is a tripeptide composed of glutamate, cysteine and glycine,
accomplishing a broad range of vital functions. Synthesis of glutathione and cysteine is performed
mainly in the liver, whereas most other tissues are supplied with these thiols via sinusoidal efflux
into the blood. Since canalicular efflux also occurs, thiols may be present in human bile. However,
thiol composition of human gallbladder bile is largely unknown, which makes it difficult to speculate
on the exact function of thiols in bile. In this study we report on the levels of non-protein bound
thiols in gallbladder bile of patients with various gastrointestinal disorders.
Methods:  Gallbladder bile was obtained after cholecystectomy from 30 patients who were
operated for pancreatic cancer, duodenal cancer, chronic pancreatitis or cholecystolithiasis. Bile
was analysed for non-protein bound total- and oxidised glutathione and related thiols, by high
performance liquid chromatography.
Results: A more than 100-fold inter-individual variation in non-protein bound thiol levels was
found in human gallbladder bile of patients with a variety of gastrointestinal disorders. Bile did
contain high amounts of cysteine, whereas much lower levels of glutathione, cysteinylglycine and
homocysteine were detected. Most thiols were present in their oxidised forms.
Conclusion: Thiols are present in considerable amounts in human gallbladder bile of patients with
various gastrointestinal disorders, levels of cysteine being much higher than those of glutathione
and other thiols. Most thiols were in their oxidised forms, which may indicate the presence of
considerable chemical- or oxidative stress in the patients studied here.
Background
Glutathione is a tripeptide composed of glutamate,
cysteine and glycine, that exists in a reduced (GSH) and
oxidised (GSSG) form. Oxidised glutathione may also
occur as protein bound glutathione (RSSG). Reduced glu-
tathione is the active form. The most widely recognised
functions of reduced glutathione are threefold: 1. main-
taining the (cellular) redox status, which is essential for
many vital biological functions, 2. protection of cells and
tissues against toxic compounds, both of endogenous and
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exogenous origin and, 3. the reservoir function of
cysteine, an important amino acid and building block of
most proteins. Since glutathione is more stable and resist-
ant against oxidation than cysteine, it serves as the pre-
ferred form of storage and transport of cysteine [1-3].
Glutathione is synthesized mainly in the liver and after
sinusoidal efflux from liver into blood plasma, glutath-
ione is transported, hydrolysed and taken up in tissues
rich in γ-glutamyl-transpeptidase (γGT), such as kidney
and lung. Thus, blood plasma serves as a transport
medium for glutathione from liver to the various other tis-
sues that are consumers of glutathione and cysteine [4].
In contrast to the hepatic sinusoidal efflux of glutathione,
the role of the canalicular efflux into bile and intestine is
less well understood [1]. Numerous studies on content
and composition of glutathione and its metabolites in
bile have been performed in bile duct canulated animals,
demonstrating that the glutathione content in bile may be
very high, depending on species [5]. Furthermore it was
shown that glutathione in animal bile may be rapidly oxi-
dised and hydrolysed [1]. In rats, the biliary content of
glutathione was shown to be lower than, but directly pro-
portional to the intrahepatic concentration [6]. Adjust-
ment of toxins to rats did increase the biliary excretion of
oxidised glutathione, thus indicating that biliary levels of
oxidised glutathione may be a good measure of oxidative-
or chemical stress [6]. This supports the main role of glu-
tathione in detoxification. Animal studies have also sug-
gested that glutathione is an osmotic driving force for the
bile acid independent bile flow [1-3]. In addition, glutath-
ione and its related thiols cysteine and cysteinylglycine,
excreted via bile, may be taken up by the (small) intestinal
epithelium, and it was suggested that this "bilio-entero-
hepatic cycle" of glutathione and related thiols may func-
tion as an extra reservoir, making more "hepatic" glutath-
ione available for sinusoidal efflux, when needed [1].
Since human bile remains in the gallbladder for several
hours, composition of thiols in the human gallbladder
bile, apart from inter-individual differences, may also be
affected by gallbladder motility, inflammatory status,
presence and number of gallbladder stones, etc. In addi-
tion, since γGT enzyme activity is high in the biliary tree
of humans, composition of the gallbladder bile may differ
considerably from that of primary canalicular bile [1,7].
Simultaneous measurements of the levels of total- and
oxidised glutathione and related thiols in human gall-
bladder bile may enlarge our knowledge on the thiol sta-
tus of the gallbladder, and possibly also that of the liver,
of a particular patient. The thiol status of gallbladder bile
may be a reflection of underlying disease, of therapeutic
intervention in (biliary) disease [7] and may be a measure
of the degree of oxidative- and/or chemical stress of an
individual. However, hardly any data on the content of
glutathione and other thiols in human gallbladder bile
are available so far. Therefore we performed a pilot study
on the levels and composition of non-protein bound
total- and oxidised glutathione and related thiols in
human gallbladder bile, obtained at surgery for pancre-
atic- or duodenal adenoma/carcinoma, chronic pancreati-
tis or cholecystolithiasis.
Methods
Patients
Gallbladder bile was collected after cholecystectomy from
30 patients, 19 males and 11 females, mean age 55 years
[range 20–80]. Patients were operated for chronic pancre-
atitis (n = 7), pancreatic cancer (n = 7), duodenal cancer
(n = 4), duodenal adenoma (n = 3), cholecystolithiasis (n
= 7) or other reasons (n = 2) at the Department of General
Surgery, Radboud University Medical Center Nijmegen,
between Januari 2004 and Januari 2006. In addition to
the primary diagnoses mentioned above, additional
cholecystitis and/or cholecystolithiasis were found
present at pathology in eight of the patients.
The study was approved by the local medical ethical
review committee (CMO regio Arnhem Nijmegen). Ver-
bal consent for the use of gallbladder specimens was
obtained from each patient.
Immediately after cholecystectomy, gallbladder bile was
collected by puncture of the gallbladder. Bile was trans-
ported to the laboratory and handled for assessment of
total non-protein bound (both reduced and oxidised) and
oxidised non-protein bound levels of cysteine (Cys and
oCys), homocysteine (Hcys and oHcys), cysteinylglycine
(CG and oCG) and glutathione (GSH and GSSG), essen-
tially as described by us for the assay of thiols in whole
blood [8]. In short, for assay of total thiol levels, 100 µL
bile was added to 100 µL ice-cold 12% perchloric acid
(PCA) containing 2.0 mM bathophenanthrolinedisul-
fonic acid (BPDS; Sigma Chemicals, Zwijndrecht, the
Netherlands). For assay of oxidised thiols, another 100 µL
bile was added to 100 µL 12% PCA containing 2.0 mM
BPDS and 40 mM N-ethylmaleimide (NEM; Sigma Chem-
icals). After thorough mixing and centrifugation at 16,000
× g for 20 min and 4°C, supernatants were collected and
stored at -80°C. Samples were analysed within one
month. The excess of NEM was removed by adding 70 µL
KOH (2.0 M) followed by 60 µL HCl (0.01 M in 0.3 M 3-
[N-morpholino]-propanesulfonic acid buffer) to 100 µL
of the sample. In the assay, 100 µL sample or standard was
reduced by adding 10 µL tris(2-carboxyethyl)phospine
(Fluka Chemie AG, Bornem, the Netherlands; 10% (w/v)
in 0.9% sodium chloride/4.0 mM EDTA) and incubation
at room temperature for 30 min. After reduction, 100 µLBMC Gastroenterology 2007, 7:7 http://www.biomedcentral.com/1471-230X/7/7
Page 3 of 4
(page number not for citation purposes)
PCA (0.6 M with 1.0 mM EDTA) was added and samples
were subsequently mixed and centrifuged for 5 min at
10,000 × g. Clear supernatant (100 µL) was incubated for
1 hour and 60°C with 240 µL reaction-mixture containing
20 µL NaOH (1.55 M), 200 µL borate buffer (125 mM
K2B4O7·4H2O and 4.0 mM EDTA, pH 9.0), and 20 µL 7-
fluorobenzofurazane-4-sulfonic acid (Fluka Chemie; 5
mg/mL in borate buffer). Of the derivatised sample, 20 µL
was subjected to high performance liquid chromatogra-
phy with fluorescent detection, using an autosampler
(Model Marathon, Spark Holland), solvent delivery sys-
tem (High Precision Pump model 480, Gynkotek) and
fluorescent detector (Intelligent Spectrofluorometric
Detector model 821-FP, Jasco) operating at excitation and
emission wavelengths of 385 and 515 nm, repectively.
The column used was an Inertsil ODS-2, 100 × 3 mm (5
µm particle size) and a R2 10 × 2 mm guard column, both
from Chrompack (Middelburg, the Netherlands). The
total-to-oxidised ratio for each thiol as a measure of oxi-
dative stress was also calculated.
Data obtained were analysed with the Chromeleon chro-
matography data-system (Gynkotek, München, Ger-
many). Thiol levels were calculated using four-point
calibration curves for each thiol and were expressed in
µmol/L.
All statistical analyses were performed using SPSS (version
12.0; SPSS Inc. Chicago, USA). Since multiple testing was
performed, a p value of less than 0.01 was considered sig-
nificant.
Results
Median levels and ranges of the total non-protein bound
and oxidised thiols, glutathione, cysteine, homocysteine
and cysteinylglycine in gallbladder bile of 30 patients are
given in Table 1. Median content of cysteine (Cys) was
found highest (90.1 µmol/L), followed by cysteinylgly-
cine (CG, 11.3 µmol/L) and glutathione (GSH, 7.0 µmol/
L), whereas only minor amounts of homocysteine (Hcys,
0.5 µmol/L) were present in human gallbladder bile. Most
thiols were present in their oxidised forms; 100%, 86%
and 81% for Hcys, CG and Cys, respectively, except for
glutathione which was found for only 40% in its oxidised
form. This trend was also reflected in the median ratios of
total non-protein bound/oxidised thiol; RCys, RHcys,
RCG and RGSH, which were 1.3, 0.8, 1.2 and 1.9, respec-
tively.
No associations were found between mean levels of any
thiol and age, gender or primary diagnosis of the patients.
Only tendencies for higher levels of total CG (17.2 vs.
24.0 µmol/L, p = 0.026) and oxidised CG (14.4 vs. 21.3
µmol/L, p = 0.025) were found in male vs. female
patients, respectively. When the gallbladder bile thiol lev-
els of patients without gallbladder pathology (n = 15)
were compared with those of patients with cholecystitis
with/or without cholecystolithiasis (n = 15), tendencies
for lower total glutathione (21.4 vs. 12.7 µmol/L, p =
0.050) and lower oxidised glutathione levels (8.2 vs. 5.4
µmol/L, p = 0.067) in patients without gallbladder
pathology were noticed.
Discussion
The composition of human gallbladder bile with respect
to glutathione and related thiols was studied. Earlier data
on biliary excretion of glutathione or related thiols and
their composition in bile were obtained almost exclu-
sively from studies on laboratory animals, mainly rats.
Except from other species differences between humans
and rats, a main difference is the absence in rats of a gall-
bladder as a reservoir of bile. Another important differ-
ence is that most animal studies in general are performed
on completely homogeneous study populations, showing
relatively little variations between individual animals,
which all receive the same standard diet, whereas in our
study gallbladder bile of a heterogeneous patient popula-
tion was investigated, which may be a main cause of vari-
ation. Glutathione was found to be the most prominent
thiol present in bile of rats and mice, followed by CG and
Cys, whereas in human gallbladder bile levels of Cys were
highest, followed by CG and GSH, Hcys being hardly
detectable. In rodents, concentrations of glutathione in
bile were in the order of several mmol/L [1,5,6] whereas
in human gallbladder bile, glutathione concentrations of
only up to 0.1 mmol/L were found. These large differences
may be either the result of species differences between
humans and rodents, may be due to the various (gallblad-
der) disorders of the patients studied here, or may depend
on the high levels of γ-glutamyl-transpeptidase in the bil-
iary tree or gallbladder epithelium of humans, which may
lead to rapid degradation of glutathione into GC and Cys.
Table 1: Levels and ratios of total non-protein bound and 
oxidised thiols in human gallbladder bile.
Thiol N Median Range
Cys (µmol/L) 30 90.1 1.4–404
oCys (µmol/L) 30 69.2 0.8–488
R Cys/oCys 30 1.3 0.6–3.8
Hcys (µmol/L) 30 0.5 0.0–2.9
oHcys (µmol/L) 30 0.6 0.0–3.2
R Hcys/oHcys* 22 0.8 0.5–5.0
CG (µmol/L) 30 11.3 0.5–84.0
oCG (µmol/L) 30 8.9 1.3–81.3
R CG/oCG 30 1.2 0.4–1.8
GSH (µmol/L) 30 7.0 0.0–106
GSSG (µmol/L) 30 2.7 0.0–34.2
R GSH/GSSG* 25 1.9 0.5–5.3
*Note that some ratios (Hcys/oHcys and GSH/GSSG) could not be 
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Thiol levels of gallbladder bile showed considerable inter-
individual variation; several hundred-fold for Cys and CG
whereas GSH values varied between 0–106 µmol/L. It
should be noted once again, that the gallbladder bile
investigated here was not obtained from healthy individ-
uals but from patients with a variety of serious gastrointes-
tinal diseases, which could contribute significantly to the
huge inter-individual variation in thiol levels. Animal
studies suggested that biliary concentrations of thiols may
reflect the concentrations in the liver [6]. When a similar
mechanism is present in humans, this would mean that
hepatic concentrations are critically low in some of the
patients investigated here, since very low concentrations
(<2.5 µmol/L) of glutathione were measured in the gall-
bladder bile of 6 out of 30 individuals.
Also in contrast to the findings in animal studies are the
much higher amounts of oxidised thiols, detected in
human bile. Most of Cys, CG and Hcys in human bile is
present in the oxidised form, whereas in animal bile most
thiols are present in their reduced state. This could be
explained by the fact that healthy animals were investi-
gated, having little oxidative or chemical stress, whereas
the gallbladder bile analysed here was obtained from
patients after surgery for a variety of reasons. These
patients were subjected to chemical stress such as anes-
thetics and medication, and oxidative stress as a result of
the surgical intervention or the underlying disease, in
most patients being cancer or (severe) inflammatory dis-
ease.
Conclusion
This pilot study on the thiol composition of human gall-
bladder bile, obtained at surgery for a variety of gastroin-
testinal disorders, reveals that:
-Levels of cysteine are highest whereas levels of glutath-
ione and other related thiols are much lower.
-Most thiols are in the oxidised state, possibly indicating
considerable oxidative or chemical stress in the patients
under study here.
-Large (several hundred-fold) inter-individual variation in
thiol levels exists. Whether this large variation may be
caused by the gallbladder pathology, by the health and
disease status of the patient, or by biological variation
between individuals, remains to be investigated.
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